| 000 | 01355 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514031608.0 | ||
| 264 | 0 | _c20020509 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.58.8_suppl_4.s3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDhib-Jalbut, Suhayl | |
| 245 | 0 | 0 |
_aMechanisms of action of interferons and glatiramer acetate in multiple sclerosis. _h[electronic resource] |
| 260 |
_bNeurology _cApr 2002 |
||
| 300 |
_aS3-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xdrug effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aGlatiramer Acetate |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 | _aInterferon beta-1b |
| 650 | 0 | 4 |
_aInterferon-beta _xadverse effects |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aPeptides _xadverse effects |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 773 | 0 |
_tNeurology _gvol. 58 _gno. 8 Suppl 4 _gp. S3-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.58.8_suppl_4.s3 _zAvailable from publisher's website |
| 999 |
_c11872657 _d11872657 |
||